416 related articles for article (PubMed ID: 10919714)
1. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC
Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
Liu XH; Kirschenbaum A; Lu M; Yao S; Dosoretz A; Holland JF; Levine AC
J Biol Chem; 2002 Dec; 277(51):50081-6. PubMed ID: 12401798
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC
J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 promotes prostate cancer progression.
Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
[TBL] [Abstract][Full Text] [Related]
5. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
Zhong H; Willard M; Simons J
Int J Cancer; 2004 Nov; 112(4):585-95. PubMed ID: 15382039
[TBL] [Abstract][Full Text] [Related]
6. PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells.
Eibl G; Bruemmer D; Okada Y; Duffy JP; Law RE; Reber HA; Hines OJ
Biochem Biophys Res Commun; 2003 Jul; 306(4):887-97. PubMed ID: 12821125
[TBL] [Abstract][Full Text] [Related]
7. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M
Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic regulation of angiopoietin-2 expression in endothelial cells.
Pichiule P; Chavez JC; LaManna JC
J Biol Chem; 2004 Mar; 279(13):12171-80. PubMed ID: 14702352
[TBL] [Abstract][Full Text] [Related]
10. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.
Murono S; Inoue H; Tanabe T; Joab I; Yoshizaki T; Furukawa M; Pagano JS
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6905-10. PubMed ID: 11381123
[TBL] [Abstract][Full Text] [Related]
11. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.
Nithipatikom K; Isbell MA; Lindholm PF; Kajdacsy-Balla A; Kaul S; Campell WB
Clin Exp Metastasis; 2002; 19(7):593-601. PubMed ID: 12498388
[TBL] [Abstract][Full Text] [Related]
12. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.
Gallo O; Franchi A; Magnelli L; Sardi I; Vannacci A; Boddi V; Chiarugi V; Masini E
Neoplasia; 2001; 3(1):53-61. PubMed ID: 11326316
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor content in metastasizing and nonmetastasizing Dunning prostatic adenocarcinoma.
Häggström S; Bergh A; Damber JE
Prostate; 2000 Sep; 45(1):42-50. PubMed ID: 10960841
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
Ghosh AK; Hirasawa N; Niki H; Ohuchi K
J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
[TBL] [Abstract][Full Text] [Related]
18. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia.
Lukiw WJ; Ottlecz A; Lambrou G; Grueninger M; Finley J; Thompson HW; Bazan NG
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4163-70. PubMed ID: 14507857
[TBL] [Abstract][Full Text] [Related]
19. COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells.
Meyer-Siegler K
Mol Med; 2001 Dec; 7(12):850-60. PubMed ID: 11876163
[TBL] [Abstract][Full Text] [Related]
20. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
Liu XH; Yao S; Kirschenbaum A; Levine AC
Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]